Immediate Discontinuation of Xanax for Insomnia Treatment

Introduction to Xanax Discontinuation

• The American College of Physicians recommends discontinuing Xanax (alprazolam) immediately due to serious safety concerns, including dementia, falls, fractures, and lack of evidence for efficacy, and instead starting cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment, with consideration of ramelteon 8 mg or low-dose doxepin 3-6 mg as pharmacologic alternatives if CBT-I alone is insufficient 1, 2, 3

Risks Associated with Xanax

• Benzodiazepines like Xanax are associated with serious adverse effects, including dementia, serious injury, and fractures, as demonstrated by observational studies 1, 2
• FDA labels warn of daytime impairment, "sleep driving," behavioral abnormalities, and worsening depression 2

Evidence-Based Treatment Algorithm

• The American College of Physicians recommends CBT-I as first-line treatment, stating it "provides better overall value than pharmacologic treatment" because it is noninvasive with fewer harms 1, 2
• CBT-I demonstrates sustained benefits after treatment discontinuation, unlike medications 3
• CBT-I components include: stimulus control therapy, sleep restriction therapy, relaxation techniques, and cognitive restructuring 3

Pharmacologic Alternatives

• Ramelteon 8 mg at bedtime is a preferred choice with zero addiction potential and no DEA scheduling, reducing sleep latency by approximately 9-13 minutes 3, 4
• Low-dose doxepin 3-6 mg is highly effective with minimal side effects and no addiction potential, specifically effective for wake after sleep onset (WASO) 3

Critical Monitoring and Safety Considerations

• Use the lowest effective dose for the shortest duration possible 2, 3
• Schedule regular follow-up every few weeks initially to assess effectiveness, side effects, and ongoing medication need 3, 4
• FDA recommends that insomnia not remitting within 7-10 days should prompt further evaluation 2
• Pharmacologic treatments are FDA-approved for short-term use only (4-5 weeks), and patients should not continue for extended periods 2